Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NO MALIGNANCY”

561 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 561 results

Not applicableUnknownNCT02789891
What this trial is testing

Randomized Controlled Trials on Laparoscopic No. 14v LNS Dissection

Who this might be right for
Stomach Neoplasms
Fujian Medical University 326
Not applicableNo Longer AvailableNCT05941637
What this trial is testing

An Expanded Access Program to Axitinib is Available for Patients With Advanced Forms of Kidney Cancer (Ductal; Papillary; Chromophobic; Oncocytic) With Mutations in VHL, PBRM1 / BAP1, SETD2, VEGF)

Who this might be right for
Clear Cell Kidney CancerKidney CancerKidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations
Lynkcell Europe
Not applicableLooking for participantsNCT05315154
What this trial is testing

Sentinel Lymph Node Biopsy Versus No Axillary Surgery in Early Breast Cancer

Who this might be right for
Breast Cancer
University of Campinas, Brazil 800
Testing effectiveness (Phase 2)Active Not RecruitingNCT04864067
What this trial is testing

No Operation After Short Course Radiotherapy Followed By Consolidation Chemotherapy In Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Servicio de Salud Metropolitano Sur Oriente 73
Not applicableStudy completedNCT00899457
What this trial is testing

Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants

Who this might be right for
Healthy, no Evidence of DiseaseLung Cancer
Vanderbilt-Ingram Cancer Center 37
Testing effectiveness (Phase 2)Ended earlyNCT00776100
What this trial is testing

Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Large-scale testing (Phase 3)Study completedNCT03645018
What this trial is testing

Lung Cancer Early Diagnosis With Digital Tomosynthesis: Re-evaluation of Lung Nodule Detection Rate at 5 Years

Who this might be right for
Lung Cancer
Ospedale Santa Croce-Carle Cuneo 1,341
Large-scale testing (Phase 3)Study completedNCT00103168
What this trial is testing

Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal Tumor
European Organisation for Research and Treatment of Cancer - EORTC 908
Not applicableStudy completedNCT04815876
What this trial is testing

PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy 2

Who this might be right for
Infection
Weill Medical College of Cornell University 1,030
Not applicableLooking for participantsNCT00588068
What this trial is testing

Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 2,070
Testing effectiveness (Phase 2)UnknownNCT03123445
What this trial is testing

Endostar First-line Treatment of Advanced NSCLC

Who this might be right for
Non Small Cell Lung Cancer
China Medical University, China 150
Testing effectiveness (Phase 2)Ended earlyNCT04871529
What this trial is testing

Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)

Who this might be right for
Bladder Carcinoma Infiltrating the Muscle of the Bladder WallInfiltrating Renal Pelvis and Ureter Urothelial CarcinomaStage II Bladder Cancer AJCC v8
SWOG Cancer Research Network 6
Not applicableLooking for participantsNCT05810467
What this trial is testing

The Active Surveillance Study

Who this might be right for
Prostate Cancer
Institute of Cancer Research, United Kingdom 200
Large-scale testing (Phase 3)Study completedNCT02369653
What this trial is testing

The Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase

Who this might be right for
LymphomaAcute Lymphoblastic Leukemia
Bristol-Myers Squibb 512
Large-scale testing (Phase 3)Study completedNCT03306992
What this trial is testing

Precision-exercise-prescription for Lung Cancer Patients Undergoing Surgery: The PEP Study

Who this might be right for
Non Small Cell Lung CancerSecondary Lung Cancer
University of Utah 200
Testing effectiveness (Phase 2)Looking for participantsNCT06778382
What this trial is testing

Delayed Systemic Therapy Following Destructive Local Treatment of Pulmonary Oligometastases After No Evidence of Disease (NED) in Colorectal Cancer.

Who this might be right for
Colorectal Neoplasms Malignant
Shandong Cancer Hospital and Institute 22
Not applicableStudy completedNCT04618874
What this trial is testing

US NAB With ROSE Versus US FNAB With no ROSE

Who this might be right for
Lung Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 136
Early research (Phase 1)Study completedNCT00968981
What this trial is testing

Hedgehog Pathway Inhibitor GDC-0449 in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists

Who this might be right for
Solid Cancers
Genentech, Inc. 67
Not applicableUnknownNCT04663789
What this trial is testing

Routine Staple Line Reinforcement for Minimally Invasive Distal Pancreatectomy

Who this might be right for
Pancreas NeoplasmStumpSurgery--Complications
Peking Union Medical College Hospital 124
Load More Results